Golden State Equity Partners’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
Other funds holding WST
Golden State Equity Partners's WST Position: Q3 2026 in Review
Golden State Equity Partners opened a new position in West Pharmaceutical (WST) in Q3 2026: 758 shares worth $281K. The stake represents 0.02% of the portfolio and ranks #686 among its holdings. This is a return to the name: Golden State Equity Partners previously reported a position in WST as recently as Q1 2026.
Golden State Equity Partners first reported a position in WST in Q2 2024 and has held it in 4 quarters since. The position peaked at $407K in Q2 2024. 881 funds tracked by Wall St. Rank hold WST as of Q3 2026.
- Golden State Equity Partners held 758 shares of West Pharmaceutical worth $281K as of Q3 2026.
- West Pharmaceutical was a new Golden State Equity Partners position in Q3 2026.
- West Pharmaceutical made up 0.02% of Golden State Equity Partners's portfolio in Q3 2026, its #686 holding.
- Golden State Equity Partners first reported a position in West Pharmaceutical in Q2 2024 and has held it in 4 quarters since.
- Golden State Equity Partners's West Pharmaceutical position peaked at $407K in Q2 2024.
- 881 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.
Based on Golden State Equity Partners's 13F filing for Q3 2026, filed 3 Nov 2026.